DHODH Inhibitors

DHODH inhibitors comprise a diverse class of chemical compounds that target and block the activity of the enzyme dihydroorotate dehydrogenase (DHODH). This pivotal enzyme is an integral component of the de novo pyrimidine biosynthesis pathway, responsible for generating pyrimidine nucleotides, essential building blocks for DNA and RNA synthesis. By hampering DHODH's function, these inhibitors disrupt the production of pyrimidine nucleotides, thereby influencing crucial cellular processes, including cell growth and proliferation. The field of DHODH inhibitors holds immense significance in fundamental research. Scientists employ these inhibitors to unravel the intricate mechanisms governing pyrimidine biosynthesis and other cellular pathways that depend on these nucleotides. By understanding the interactions between DHODH and its inhibitors, researchers can gain valuable insights into the molecular basis of various diseases, such as cancer, immunological disorders, and viral infections.The exploration of DHODH inhibitors offers promising avenues for drug discovery. The potential applications of DHODH inhibitors in oncology, immunology, and antiviral research continue to be of great interest to the scientific community. Despite the ongoing progress in the field, it is essential to note that DHODH inhibitors are still subjects of intensive investigation. Their intricate mechanisms of action and the full scope of their potential applications are continuously being explored by researchers worldwide.